About ALA
Arovella Therapeutics Limited (ALA, formerly Suda Pharmaceuticals Ltd) is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours.
Find out what a historical investment in Arovella Therapeutics would be worth today using our ALA stock calculator.
Market Capitalisation
$62.86M
Price-earnings ratio
-8.28
Dividend yield
-
High today
$0.05
Low today
$0.05
Open price
$0.05
52-week high
$0.10
52-week low
$0.05
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ALA
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in ALA on Stake
- Buy ALA from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
ALA related stocks